Brian Davis, RPh

Vice President, Payer Strategy


Digital Health, Digital Medicine, Digital Technology, Pricing, Reimbursement & Market Access, Stakeholder Engagement & Promotion (Patients, Payers, Providers)

Brian is a seasoned healthcare expert with more than 15 years of experience working in compliance, pharmacy benefit design, market access, and provider reimbursement. Throughout his career, Brian has leveraged his deep understanding of healthcare policy, real-world evidence generation, and data analysis to develop market access and reimbursement strategies and compelling value narratives for his clients.

In a previous role, he led payer strategy for a specialty pharmacy provider and served as a point negotiator for variable provider network contracts and trade contracts for supply chain, preferred status/formulary, 340b, and reimbursement across all therapeutic categories based in USP model guidelines.

Brian has served as a compliance lead for FA, CDAG, MTM, and FWA for government programs, including MAPD, PDP, MMP, and Medicaid.

Earlier in Brian’s career, he gained firsthand experience working with ERISA plans, state departments of insurance, CMS/Medicare and Medicaid, snd sterile compounding, nuclear, specialty, and retail pharmacy.

Brian holds an MS in pharmacy from the University of Florida and a BS in pharmacy from the St. Louis College of Pharmacy.

Articles by Brian Davis, RPh

Global Pharma Pricing Regulations
The Transforming Landscape of Digital Therapeutics Reimbursement

The Transforming Landscape of Digital Therapeutics Reimbursement Over recent months, healthcare delivery has changed dramatically to drive utilization to more specialized treatment options, such as specialty drugs and digital therapeutics (DTx). While new technology is generally welcomed in the market, navigating the reimbursement pathway and determining appropriate coverage for these novel therapeutics can be challenging. […]

Two Key Questions About Payer Strategies in 2020

In a PM360 Focus on Payer Strategies feature, Brian Davis addresses the question: Besides efforts to lower drug prices and increase transparency, what market access challenges/barriers will cause pharma companies the most stress this year? How can companies overcome this challenge/barrier? In his response, Brian highlights a few of the 2020 challenges to market access, […]

The Impact of Technology on Advancing Diabetes Care

Statistics from the World Health Organization report that over the past 25+ years, the number of people around the world diagnosed with diabetes has almost quadrupled to 422 million. According to the Centers for Disease Control, diabetes is the seventh leading cause of death in the United States with an annual financial impact of $327 […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.